Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections.
Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ. Raad II, et al. Among authors: graybill jr. Clin Infect Dis. 2006 Jun 15;42(12):1726-34. doi: 10.1086/504328. Epub 2006 May 8. Clin Infect Dis. 2006. PMID: 16705579 Clinical Trial.
Salvage treatment of histoplasmosis with posaconazole.
Restrepo A, Tobón A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, Pankey G, Moore T, Negroni R, Graybill JR. Restrepo A, et al. Among authors: graybill jr. J Infect. 2007 Apr;54(4):319-27. doi: 10.1016/j.jinf.2006.05.006. Epub 2006 Jul 7. J Infect. 2007. PMID: 16824608 Clinical Trial.
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Wiederhold NP, Najvar LK, Bocanegra R, Graybill JR, Patterson TF. Wiederhold NP, et al. Among authors: graybill jr. Antimicrob Agents Chemother. 2010 Mar;54(3):1055-9. doi: 10.1128/AAC.01445-09. Epub 2010 Jan 11. Antimicrob Agents Chemother. 2010. PMID: 20065054 Free PMC article.
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. Segal BH, et al. Among authors: graybill jr. Clin Infect Dis. 2008 Sep 1;47(5):674-83. doi: 10.1086/590566. Clin Infect Dis. 2008. PMID: 18637757 Free PMC article. Review.
273 results